Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Toronto - Delayed Quote CAD

Aptose Biosciences Inc. (APS.TO)

Compare
2.8000
-0.1300
(-4.44%)
At close: April 15 at 2:28:56 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
26,257
26,257
52,356
42,602
65,447
Operating Income
-26,257
-26,257
-52,356
-42,602
-65,447
Net Non Operating Interest Income Expense
150
150
1,151
788
94
Other Income Expense
677
677
-2
-9
-1
Pretax Income
-25,430
-25,430
-51,207
-41,823
-65,354
Net Income Common Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Diluted NI Available to Com Stockholders
-25,430
-25,430
-51,207
-41,823
-65,354
Basic EPS
-36.38
--
-227.43
-204.00
-328.50
Diluted EPS
-36.38
--
-227.43
-204.00
-328.50
Basic Average Shares
698.9790
--
225.1540
205.0330
197.9680
Diluted Average Shares
698.9790
--
225.1540
205.0330
197.9680
Total Expenses
26,257
26,257
52,356
42,602
65,447
Net Income from Continuing & Discontinued Operation
-25,430
-25,430
-51,207
-41,823
-65,354
Normalized Income
-26,107
-26,107
-51,205
-41,814
-65,353
Interest Income
357
357
1,151
788
94
Interest Expense
207
207
--
--
--
Net Interest Income
150
150
1,151
788
94
EBIT
-25,223
-25,223
-51,207
-42,602
-65,447
EBITDA
-24,819
-24,819
-50,741
-42,074
-64,825
Reconciled Depreciation
404
404
466
528
622
Net Income from Continuing Operation Net Minority Interest
-25,430
-25,430
-51,207
-41,823
-65,354
Total Unusual Items Excluding Goodwill
677
677
-2
-9
-1
Total Unusual Items
677
677
-2
-9
-1
Normalized EBITDA
-25,496
-25,496
-50,739
-42,065
-64,824
12/31/2021 - 4/25/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ONC.TO Oncolytics Biotech Inc.
0.8000
-5.88%
 
MBX.TO Microbix Biosystems Inc.
0.3500
-5.41%
 
MDNA.TO Medicenna Therapeutics Corp.
0.9800
+8.89%
 
RNTX Rein Therapeutics Inc.
1.7200
+3.61%
 
PHRM.CN PharmaTher Holdings Ltd.
0.2050
+2.50%
 
DMN.F Diamyd Medical AB (publ)
0.6490
-3.71%
 
FRX.TO Fennec Pharmaceuticals Inc.
7.58
0.00%
 
CGTX Cognition Therapeutics, Inc.
0.3833
-2.72%
 
RNXT RenovoRx, Inc.
0.9000
+6.53%
 
RVX.TO Resverlogix Corp.
0.0400
+14.29%